Condition: Heart Failure (HF) · Sponsor: Aventusoft, LLC.
Evaluation of the HEMOTAG® system in a less controlled environment and concurrently develop the system for use by patients with heart failure.
This description comes directly from the study's public registry record.
Cindy Kober · 561-945-9303 · cindy@aventusoft.com
Kaustubh Kale · 954-399-3335 · kaustubh@aventusoft.com
Always discuss trial participation with your own doctor first.
| Cleveland Clinic Florida | Weston, Florida, United States | Recruiting |
| Baylor Scott & White Research Institute | Temple, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04149743